84 related articles for article (PubMed ID: 16137997)
21. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.
Dolinsky CM; Mahmoud NN; Mick R; Sun W; Whittington RW; Solin LJ; Haller DG; Giantonio BJ; O'Dwyer PJ; Rosato EF; Fry RD; Metz JM
J Surg Oncol; 2007 Sep; 96(3):207-12. PubMed ID: 17443718
[TBL] [Abstract][Full Text] [Related]
22. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
23. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
24. Treatment perspectives in locally advanced unresectable pancreatic cancer.
Jeekel J; Treurniet-Donker AD
Br J Surg; 1991 Nov; 78(11):1332-4. PubMed ID: 1760697
[TBL] [Abstract][Full Text] [Related]
25. Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: a feasibility study at tertiary care centre.
Kapoor R; Khosla D; Gupta R; Bahl A; Shukla AK; Sharma SC
Indian J Cancer; 2014; 51(2):176-9. PubMed ID: 25104204
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma.
Macchia G; Valentini V; Mattiucci GC; Mantini G; Alfieri S; Digesù C; Deodato F; Trodella L; Doglietto GB; Cellini N; Morganti AG
Tumori; 2007; 93(1):53-60. PubMed ID: 17455872
[TBL] [Abstract][Full Text] [Related]
27. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
[TBL] [Abstract][Full Text] [Related]
28. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer.
Shinchi H; Takao S; Noma H; Matsuo Y; Mataki Y; Mori S; Aikou T
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):146-50. PubMed ID: 12007953
[TBL] [Abstract][Full Text] [Related]
29. Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients.
Bjerregaard JK; Mortensen MB; Schønnemann KR; Pfeiffer P
Eur J Cancer; 2013 Jan; 49(1):98-105. PubMed ID: 22909997
[TBL] [Abstract][Full Text] [Related]
30. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure.
Paulino AC
Am J Clin Oncol; 1999 Oct; 22(5):489-94. PubMed ID: 10521065
[TBL] [Abstract][Full Text] [Related]
31. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
Okusaka T; Okada S; Tokuuye K; Wakasugi H; Saisho H; Ishikawa O; Matsuno S; Sato T; Sato K;
Cancer; 2001 Apr; 91(7):1384-9. PubMed ID: 11283940
[TBL] [Abstract][Full Text] [Related]
32. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.
Azria D; Ychou M; Jacot W; Thezenas S; Lemanski C; Senesse P; Prost P; Delard R; Masson B; Dubois JB
Pancreas; 2002 Nov; 25(4):360-5. PubMed ID: 12409830
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer.
Mehta VK; Fisher GA; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Poen JC
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1483-7. PubMed ID: 11121652
[TBL] [Abstract][Full Text] [Related]
34. Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas.
Evans DB
J Gastrointest Surg; 2001; 5(1):2-5. PubMed ID: 11370617
[No Abstract] [Full Text] [Related]
35. Role of radiation therapy in the management of pancreatic cancer.
Goodman KA; Hajj C
J Surg Oncol; 2013 Jan; 107(1):86-96. PubMed ID: 22532174
[TBL] [Abstract][Full Text] [Related]
36. Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer.
Cassinotto C; Sa-Cunha A; Trillaud H
Diagn Interv Imaging; 2016 Dec; 97(12):1225-1232. PubMed ID: 27692675
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer.
Lutfi W; Talamonti MS; Kantor O; Wang CH; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
Am J Surg; 2017 Mar; 213(3):521-525. PubMed ID: 28089341
[TBL] [Abstract][Full Text] [Related]
38. Stage III pancreatic cancer and the role of irreversible electroporation.
Al Efishat M; Wolfgang CL; Weiss MJ
BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer.
Mukherjee S; Hudson E; Reza S; Thomas M; Crosby T; Maughan T
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):535-40. PubMed ID: 18346883
[TBL] [Abstract][Full Text] [Related]
40. An international comparison of treatment and short-term overall survival for older patients with pancreatic cancer.
de Leede N; Bastiaannet E; van der Geest L; Egan K; van de Velde C; Balducci L; Bonsing B; Extermann M
J Geriatr Oncol; 2019 Jul; 10(4):584-590. PubMed ID: 30799177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
